ARTICLE | Company News
Antitope, Cantab Biopharmaceuticals deal
March 29, 2010 7:00 AM UTC
Antitope will generate a high-yielding manufacturing mammalian cell line to develop a "biosuperior" protein therapeutic for a hematologic indication for Cantab. Further terms were not disclosed. ...